Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA4 | P22748 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29527726 | 1.00 | PARP1 (0.58) | PARP1KDM4ETDP1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4837088 | 1.00 | PARP1 (0.58) | PARP1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL27402566 | 0.88 | KDM4E (0.52) | PARP1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL27633078 | 0.87 | KDM4E (0.50) | PARP1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL28451126 | 0.84 | PARP1 (0.50) | PARP1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL10662269 | 0.84 | CDC25B (0.57) | PARP1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL11054412 | 0.84 | CA12 (0.55) | KDM4ETDP1MEN1KMT2ACA12 | |
| SCHEMBL1531500 | 0.84 | KDM4E (0.62) | KDM4ETDP1MEN1KMT2ACA12 | |
| Hydrochloric Acid SCHEMBL808814 | 0.83 | CYP1A2 (0.60) | KDM4ETDP1MEN1KMT2ACA12 | |
| SCHEMBL9016205 | 0.82 | CA12 (0.62) | KDM4ETDP1MEN1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 946 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3592761-B1 | NEW ANTIBACTERIAL PRODUCTS | UNIV LIVERPOOL (GB) | 2025-05-14 | — | — | EP | claimed |
| WO-2024256834-A1 | TEIXOBACTINS ANALOGUES AS ANTI-BIOFILM AGENTS | UNIVERSITY OF LIVERPOOL (GB) | 2024-12-19 | — | — | WO | claimed |
| US-20240368224-A1 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | OHIO STATE INNOVATION FOUNDATION | 2024-11-07 | — | — | US | claimed |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-10-03 | — | — | US | claimed |
| EP-4358989-A2 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | Ohio State Innovation Foundation (US) | 2024-05-01 | — | — | EP | claimed |
| US-11897970-B2 | Antibacterial products | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-02-13 | — | — | US | claimed |
| WO-2022271810-A2 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | OHIO STATE INNOVATION FOUNDATION (US) | 2022-12-29 | — | — | WO | claimed |
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2021-05-13 | — | — | US | claimed |
| CN-110582506-A | Novel antimicrobial products | 林肯大学 | 2019-12-17 | — | — | CN | claimed |
| WO-2018162922-A1 | NEW ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LINCOLN (GB) | 2018-09-13 | — | — | WO | claimed |
| EP-0764151-A2 | PURIFICATION OF SERINE PROTEASE AND SYNTHETIC INHIBITORS THEREOF | UNIVERSITAIRE INSTELLING ANTWERPEN (BE) | 1997-03-26 | — | — | EP | claimed |
| US-5541348-A | Bile acids for biological and chemical applications and processes for the production thereof | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1996-07-30 | — | — | US | claimed |
| WO-1995034538-A2 | PURIFICATION OF SERINE PROTEASES AND SYNTHETIC INHIBITORS THEREOF | UNIVERSITAIRE INSTELLING ANTWERPEN (BE) | 1995-12-21 | — | — | WO | claimed |
| EP-0464488-B1 | Optically active N-alpha-fluoroacryloyl-aminoacid derivatives, their preparation, optically active polymers prepared therefrom and their use for the separation of racemates | BAYER AG (DE) | 1995-09-27 | — | — | EP | claimed |
| EP-0584664-A1 | Polymerizable dipeptides: preparation, polymerization and use of polymers for the chromatographic separation of enantiomers | BAYER AG (DE) | 1994-03-02 | — | — | EP | claimed |
| EP-0299793-B1 | PACKING MATERIALS FOR ANALYSING ENANTIOMER MIXTURES BY LIQUID CHROMATOGRAPHY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-31 | — | — | EP | claimed |
| EP-0464488-A2 | Optically active N-alpha-fluoroacryloyl-aminoacid derivatives, their preparation, optically active polymers prepared therefrom and their use for the separation of racemates | BAYER AG (DE) | 1992-01-08 | — | — | EP | claimed |
| EP-0299793-A2 | Packing materials for analysing enantiomer mixtures by liquid chromatography | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-01-18 | — | — | EP | claimed |
| US-4578386-A | CONGESTIVE HEART FAILURE | USV PHARMACEUTICAL CORP. (US) | 1986-03-25 | — | — | US | claimed |
| US-4459349-A | A 2-NAPHTHYL-4,5-DIPHENYLIMIDAZOLYL DIMER, UNSATURATED MONOMER | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1984-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | DBI, MRPL21, NRDC | PARP1 2819/4885KDM4E 3275/4885TDP1 4757/4885 |
| US-20240368224-A1 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | KRAS, HRAS, NRAS | PARP1 1631/4885KDM4E 4608/4885TDP1 3235/4885 |
| US-11897970-B2 | Antibacterial products | DBI, PDIA5, ABCB11 | PARP1 2440/4885KDM4E 2792/4885TDP1 4630/4885 |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | DBI, PDIA5, ABCB11 | PARP1 2440/4885KDM4E 2792/4885TDP1 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.